[1]CurrentPatentAssignee:UNIVERSITYOFPARMA;UNIVERSITYOFCALIFORNIA;GUIDUCCIGIOVANNA;UNIVERSITYOFURBINO-WO2012/15704,2012,A2
Title: Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.
Journal: Pharmacological research 20120501
Title: The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system.
Journal: Pharmacological research 20111001
Title: Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
Journal: Nature neuroscience 20101001
Title: Jason R Clapper, et al. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat Neurosci. 2010 Oct;13(10):1265-70.
Title: Valentina Vozella, et al. Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase (FAAH) inhibitor, in rats. J Pharm Pharmacol. 2019 Dec;71(12):1762-1773.
Title: G Moreno-Sanz, et al. Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier. Br J Pharmacol. 2012 Dec;167(8):1620-8.
Title: Rui Li, et al. The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced Lung Injury in a Mouse Model. Inflammation. 2017 Aug;40(4):1254-1263.
